Company newsCompany release
Thermo Fisher Scientific authorizes up to $5 billion in share repurchases
The authorization has no expiration date and replaces the company's existing repurchase authorization, of which $1 billion was remaining.
GetSignal
Thermo Fisher Scientific said on November 5, 2026, that its board of directors has authorized the repurchase of up to $5 billion of its common stock, in the open market or in negotiated transactions.
Key facts
- Authorization
- Up to $5 billion of common stock
- Methods
- Open market or negotiated transactions
- Expiration
- None
- Prior authorization remaining
- $1 billion
Source: The company's release on Business Wire, November 5, 2026.
Written by GetSignal with AI from the company's press release. How we make news
Not investment advice.
More company news
The newest- Canadian Natural Resources agrees to acquire Advantage Energy
CNQ · Canadian Natural Resources · Company release · Nov 16, 2026
- Rio Tinto, BCL and ABG agree to establish fund for Panguna mine legacy impacts
RIO · Rio Tinto Group · Company release · Nov 16, 2026
- Viking Therapeutics shares VK2735 obesity trial analysis at ObesityWeek 2026
VKTX · Viking Therapeutics · Company release · Nov 15, 2026
- CVS Health study finds GLP-1 medical savings do not fully offset pharmacy spending at current prices
CVS · CVS Health · Company release · Nov 15, 2026
- Rocket Lab reaches 100 Electron launches
RKLB · Rocket Lab · Company release · Nov 14, 2026
